NCT02899416 (BELINDA) is a clinical trial in Cardiovascular Risk Factor, sponsored by University Hospital, Lille.

Who is sponsoring NCT02899416?

NCT02899416 is sponsored by University Hospital, Lille.

What condition does NCT02899416 study?

NCT02899416 studies Cardiovascular Risk Factor.

Is NCT02899416 still recruiting?

NCT02899416 is currently completed. Last updated 23 December 2025.

Last reviewed 2025-12-23 · How we verify

NCT02899416: BELINDA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Better Life by Nutrition During Adulthood

Completed Last updated 23 December 2025

What this trial tests

trial in Cardiovascular Risk Factor in 72 participants. Completed in 25 March 2022.

Timeline

23 February 2017

Primary endpoint
25 March 2022

25 March 2022

Quick facts

Lead sponsor	University Hospital, Lille
Status	Completed
Study type	OBSERVATIONAL
Enrollment	72
Start date	23 February 2017
Primary completion	25 March 2022
Estimated completion	25 March 2022
Sites	1 location across France

Conditions studied

Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →

Sponsor

University Hospital, Lille

Who can join

Adults 20 to 35, any sex, with Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

BELINDA is a follow'up of subjects included 10 years ago in HELENA study which was a cross-sectional study carried out from 2006 to 2007 in more than 3500 adolescents aged from 12.5 to 17.5 years old through 10 Europeans towns from 9 countries. BELINDA main objective is to assess CV risk using PDAY score (Pathobiological Determinants of Atherosclerosis in Youth) during young adulthood (20 to 31 years) and analyze lifestyle risk factors from adolescence (12 to 18 years). This analyze may define new CV risk factors and risk population cluster.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Changes in physical activity patterns from adolescence to young adulthood: the BELINDA study.
Vanhelst J, Béghin L, Drumez E, Labreuche J, et al · · 2023 · cited 18× · PMID 37058152 · DOI 10.1007/s00431-023-04948-8
Nutritional and physical fitness parameters in adolescence impact cardiovascular health in adulthood.
Morcel J, Béghin L, Michels N, De Ruyter T, et al · · 2024 · cited 10× · PMID 38959665 · DOI 10.1016/j.clnu.2024.06.022
Are anxiety and depression associated with cognition and cardiovascular function in young male and female adults?
Ruthmann F, Guerouaou N, Vasseur F, Migaud MC, et al · · 2023 · cited 7× · PMID 37851601 · DOI 10.1371/journal.pone.0292246
Identification of Lifestyle Risk Factors in Adolescence Influencing Cardiovascular Health in Young Adults: The BELINDA Study.
Morcel J, Béghin L, Michels N, Vanhelst J, et al · · 2022 · cited 2× · PMID 35631230 · DOI 10.3390/nu14102089
High nutritional knowledge during adolescence is associated with healthier dietary habits in adulthood: a longitudinal cohort study.
Béghin L, Morcel J, Michels N, Leroy M, et al · · 2026 · PMID 42228155 · DOI 10.1007/s00394-026-03968-y

Verify or expand the search:

Other recruiting trials for Cardiovascular Risk Factor

Currently open trials in the same condition.

NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
NCT06225544 — Lumasiran in Hyperoxalaemic Patients on Haemodialysis · Phase 2 · recruiting
NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting
NCT05887622 — The Potassium Supplementation Study · NA · recruiting
NCT04962061 — A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors. · NA · recruiting

Other University Hospital, Lille trials

Trials by the same sponsor.

NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02899416 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
Last refreshed: 23 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02899416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing